United Kingdom · How much has Neurocentrx Pharma raised?
Neurocentrx Pharma has raised $135M across 1 round since 2025.
United Kingdom · Funded startup
Who invested in Neurocentrx Pharma
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Neurocentrx Pharma and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$135Mraised across 1 round since 2025, from 1 source
- Latest round
- Round, $135MOct 2025
- Investors
- 0
The rounds
- Oct 2025Round$135M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Funding filed with regulators
Neurocentrx Pharma filed one raise, $135M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Oct 2025$135MUK share allotment
Quick answers about Neurocentrx Pharma
When did Neurocentrx Pharma last raise?
Neurocentrx Pharma's most recent round, $135M, was in Oct 2025.
What was Neurocentrx Pharma's biggest round?
Its most recent round, $135M in Oct 2025, is also its largest on record.
Where is Neurocentrx Pharma based?
Neurocentrx Pharma is based in the United Kingdom.
Companies like Neurocentrx Pharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.